Gastric fundoplication with endoscopic technique: A novel approach for gastroesophageal reflux disease treatment

Table 1 Patient characteristics, n (%)

Characteristic	Value
Sex
Male	11 (61.1)
Female	7 (38.9)
Age, years (mean ± SD)	35.4 ± 5.4
Initial Hill grade
IIa	4 (22.2)
IIb	14 (77.8)
Adverse events	1 (5.6)
Valve reinforcement at 12 months postoperatively	1 (5.6)

Table 2 Comparison of quality of life and DeMeester scores at the time of the procedure and 6 and 12 months postoperatively

Score	At the time of the procedure	6 months	12 months	P value
GERD-related QOL (50)	39.9 ± 4.0	8.4 ± 4.7	8.7 ± 5.0	< 0.001
GERD-related QOL (30)	21.8 ± 2.2	2.9 ± 3.3	2.5 ± 2.7	< 0.001
DeMeester	27.0 ± 6.5	10.6 ± 2.5	9.6 ± 2.4	< 0.001

GERD: Gastroesophageal reflux disease; QOL: Quality of life.

Table 3 Comparison of gastroesophageal reflux disease -related quality of life at the time of the procedure and 6 and 12 months postoperatively

Assessment, n	At the time of the procedure	6 months	12 months	P value
Satisfied	0	17	17	< 0.001
Neutral	2	1	1
Dissatisfied	16	0	0

Table 4 Treatment efficacy with gastric fundoplication with an endoscopic technique

Characteristic, n	At the time of the procedure	6 months	12 months	P value
GERD during endoscopy	13	3	1	< 0.001
Anti-GERD medications	18	3	1	< 0.001

GERD: Gastroesophageal reflux disease.